Home - Products - Others - Other Targets - Rhamnocitrin 3-apiosyl-(1->2)-glucoside

Rhamnocitrin 3-apiosyl-(1->2)-glucoside

CAS No. 148031-68-9

Rhamnocitrin 3-apiosyl-(1->2)-glucoside( —— )

Catalog No. M31893 CAS No. 148031-68-9

Rhamnocitrin 3-apiosyl-(1a 2)-glucoside is a natural product for research related to life sciences.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 311 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Rhamnocitrin 3-apiosyl-(1->2)-glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Rhamnocitrin 3-apiosyl-(1a 2)-glucoside is a natural product for research related to life sciences.
  • Description
    Rhamnocitrin 3-apiosyl-(1a 2)-glucoside is a natural product for research related to life sciences.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    148031-68-9
  • Formula Weight
    594.5
  • Molecular Formula
    C27H30O15
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pannexin - 1 Fragmen...

    Pannexin - 1 Fragment (4515)

  • Gymnemanol

    Gymnemanol is a triterpene isolated from Gymnema sylvestre (Gymnema sylvestre).

  • WKYMVM 2TFA(187986-1...

    WKYMVM 2TFA is a N-formyl peptide receptor (FPR1) agonist.Neutrophils are activated by WKYMVM through FPRL1 and that FPRL2 is a chemotactic receptor transducing signals in myeloid cells.Using blood samples withdrawn from 28 AL patients and 31 healthy controls, found that, in the absence of exogenous WKYMVm, WKYMVm receptor and bactericidal activity did not differ between patients and controls.?